NDC 43742-1366 Enterococcus Faecalis, Streptococcus Agalactiae, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Mutans, Pneumococcinum, Streptococcus Uberis, Streptococcus Viridans.
Liquid - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Code Structure Chart
Product Details
What is NDC 43742-1366?
What are Enterococcus Faecalis, Streptococcus Agalactiae, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Mutans, Pneumococcinum, Streptococcus Uberis, Streptococcus Viridans. Active Ingredients?
- ENTEROCOCCUS FAECALIS 10 [hp_M]/mL - A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.
- STREPTOCOCCUS AGALACTIAE 10 [hp_M]/mL - A bacterium which causes mastitis in cattle and occasionally in man.
- STREPTOCOCCUS DYSGALACTIAE 10 [hp_M]/mL
- STREPTOCOCCUS EQUINUS 10 [hp_M]/mL - A species of gram-positive, coccoid bacteria commonly found in the alimentary tract of cows, sheep, and other ruminants. It occasionally is encountered in cases of human endocarditis. This species is nonhemolytic.
- STREPTOCOCCUS MUTANS 10 [hp_M]/mL - A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.
- STREPTOCOCCUS PNEUMONIAE 10 [hp_M]/mL - A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
- STREPTOCOCCUS UBERIS 10 [hp_M]/mL
- STREPTOCOCCUS VIRIDANS GROUP 10 [hp_M]/mL
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
[13] What is an Unfinished Product? - This field indicates if the product is an unfinished drug. An unfinished drug is an active pharmaceutical ingredient either alone or with other ingredients that is not a finished drug product. Unfinished drugs are used to process other drugs or for drug compounding.